A Study of the Safety and Effectiveness of Topiramate on Insulin Sensitivity in Overweight or Obese Patients With Type 2 Diabetes

NCT00236626 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

38

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity
Diabetes Mellitus, Type 2
Diabetes Mellitus, Adult-Onset

Interventions

DRUG: topiramate

Sponsor

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.